As mentioned earlier, elevated IGF2 mRNA expression correlated with shorter survival in HCC, was associated with a switch from normal liver‐specific promoter P1 to the fetal P3 promoter in the IGF2 gene, and was inversely correlated with SRSF3 mRNA levels. Here, SRSF3 is linked to hepatocellular carcinoma.